Fund holders13F
Funds That Own Inhibrx Biosciences, Inc. (INBX)
2 of the 26 major funds we track reported INBX in their latest 13F, worth $112.4M combined at quarter end.
| Fund | Quarter | Shares | Value | Change |
|---|---|---|---|---|
| Viking Global Investors | Q2 2026 | 1,123,929 | $106.5M | ▼ −21.8% |
| Renaissance Technologies | Q2 2026 | 62,201 | $5.89M | ▲ +23.9% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
A 13F lists long positions in U.S.-listed stocks and some options at quarter end. It does not show short positions, cash, most foreign holdings, or trades made since. What a 13F can't tell you →